000 | 00949 a2200277 4500 | ||
---|---|---|---|
005 | 20250512003145.0 | ||
264 | 0 | _c19911001 | |
008 | 199110s 0 0 eng d | ||
022 | _a0160-2446 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSafar, M E | |
245 | 0 | 0 |
_aCardiac hypertrophy and aortic distensibility in essential hypertension. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology _c1987 |
||
300 |
_aS86-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aAorta _xphysiopathology |
650 | 0 | 4 |
_aCardiomegaly _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xphysiopathology |
700 | 1 | _aLaurent, S | |
700 | 1 | _aAsmar, R A | |
700 | 1 | _aHugue, C J | |
700 | 1 | _aLondon, G M | |
773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 10 Suppl 6 _gp. S86-90 |
|
999 |
_c2491039 _d2491039 |